University at Buffalo: Inhaled Steroid Keeps COVID-19 Patients With Mild to Moderate Disease Out of the Hospital
November 23, 2021
November 23, 2021
BUFFALO, New York, Nov. 23 (TNSJou) -- The University at Buffalo (State University of New York) issued the following news release:
* * *
Conducted in late 2020, UB-led study of ciclesonide was one of the first to look at steroids in patients with mild to moderate disease
* * *
A national study led by emergency medicine physicians at the University at Buffalo has found that patients with mild to moderate COVID-19 who are treated with an inhaled . . .
* * *
Conducted in late 2020, UB-led study of ciclesonide was one of the first to look at steroids in patients with mild to moderate disease
* * *
A national study led by emergency medicine physicians at the University at Buffalo has found that patients with mild to moderate COVID-19 who are treated with an inhaled . . .
